Entries by Evgeniy Makarevich

In the US, approved a drug for the treatment of rare blood diseases

Sanofi received a Marketing Authorization from US regulatory authorities for caplacizumab (caplacizumab) for the treatment of thrombotic thrombocytopenic purpura. This is quite a serious and rare disease. Such therapy is registered only for adult patients. This decision was made after studying the results of a clinical study that was conducted with 145 patients. Clinical trial […]

Scientific Research Institute of Highly Pure Biopreparations Resumes Production of Antioxidant

The Federal State Unitary Enterprise “State Scientific Research Institute of Highly Pure Biopreparations” FMBA decided to return to the market the original drug Rexod® (INN: superoxide dismutase), which was developed and produced by the Institute. The drug is available in a new dosage form – solution for injection. Superoxide dismutase is an endogenous acceptor of […]

The medicine created in the Russian Federation has passed clinical trials as a remedy for tick-borne encephalitis

Antiviral drug triazavirin was developed by researchers of the Ural Branch of the Russian Academy of Sciences and the Ural Federal University. Employees of the Krasnoyarsk State Medical University conducted clinical trials of antiviral drug triazavirin, developed by Ural researchers, and confirmed its effectiveness for tick-borne viral encephalitis (EEC). It was reported by the press […]

UK and Russia sign MoU on Regulatory Cooperation on Medicines

Medicines regulators of the UK and Russian set out key principles to support their collaboration on improving public health. The Medicines and Healthcare products Regulatory Agency (MHRA) has signed a Memorandum of Understanding (MoU) with its Russian counterpart; the State Institute of Drugs and Good Practices of the Ministry of Industry and Trade of the […]

New results of the Phase III clinical trial of Tafamidis

In the section of the newest clinical trials of the 22nd annual scientific conference of American society in heart failure there were the results of the sensitivity and post-hoc analysis. New analysis of death due to any cause has shown the benefits of Tafamidis in all subgroups. For example, among patients with cardiomyopathy due to […]

Statins may suspend the development of diabetic retinopathy

According to experts from Chang Gun Memorial Hospital in Taiwan, diabetic patients taking statins have a reduced risk of diabetic retinopathy. The researchers, based on information from the National Taiwan Health Insurance Policy Database, undertook a comparative analysis of patients with type 2 diabetes and high cholesterol, among whom about 19,000 patients took statins, the […]

A drug for the treatment of cancers was approved in the USA

The FDA approved Vitrakvi (Loxo Oncology) in fast forward for the treatment of cancer in adults and children with a certain genetic mutation (biomarker). As noted by the FDA, this is a second drug approved for the treating of tumors regardless of their location. Vitrakvi is intended for the treatment of adults and children with […]

Defeated virus: will the flu become a second smallpox?

With the arrival of the first colds, the number of cases of acute respiratory viral diseases increases, the most serious of which is considered the flu. According to the World Health Organization (WHO), from 10 to 15% of the world’s population is infected with influenza viruses, which leads to death, including economically developed countries. It […]

Drugs for the treatment of multiple sclerosis are included in the List of drugs for the treatment of high-cost nosologies

In accordance with the Government Regulation of the Russian Federation No. 2738-p of 10 December, a drug product is included in the list of drugs for patients with hemophilia, cystic fibrosis, pituitary ganosis, painful Gaucher syndrome, malignant neoplasms of lymphoid, hematopoietic and related tissues, multiple sclerosis, as well as persons after transplantation of organs and/ […]